TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Historical Holders from Q3 2021 to Q3 2025

Symbol
TCRX on Nasdaq
Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Shares outstanding
52,382,313
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
34,601,160
Holdings value
$62,910,264
% of all portfolios
0%
Number of holders
72
Number of buys
22
Number of sells
-42
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynx1 Capital Management LP 15% +37.3% $11,393,153 +$3,625,000 7,857,347 +46.7% Lynx1 Capital Management LP 30 Jun 2025
BIOTECHNOLOGY VALUE FUND L P 9.99% $8,421,666 5,263,541 BVF PARTNERS L P/IL 31 Mar 2025
K2 HealthVentures Equity Trust LLC 6.9% $5,764,320 3,602,700 K2 HealthVentures Equity Trust LLC 31 Dec 2024
ADAGE CAPITAL PARTNERS GP, L.L.C. 7.13% $5,600,000 3,500,000 Adage Capital Management, L.P. 31 Dec 2024
Adage Capital Management, L.P. 2.52% $1,957,500 1,350,000 Adage Capital Management, L.P. 30 Jun 2025
BlackRock, Inc. 1.8% -72% $1,475,894 -$2,875,873 958,373 -66.1% BlackRock, Inc. 30 Jun 2025
EcoR1 Capital, LLC 1.3% $1,060,533 662,833 EcoR1 Capital, LLC 31 Mar 2025

Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34,601,160 $62,910,264 -$1,894,623 $1.82 72
2025 Q2 35,724,879 $51,820,655 -$5,881,550 $1.45 79
2025 Q1 40,135,840 $55,389,702 -$2,855,488 $1.38 92
2024 Q4 41,522,755 $126,231,784 -$5,917,073 $3.04 87
2024 Q3 41,835,445 $208,343,506 +$256,552 $4.98 86
2024 Q2 41,438,662 $242,461,718 +$40,505,361 $5.85 78
2024 Q1 34,291,369 $272,339,183 +$19,079,789 $7.94 65
2023 Q4 31,912,819 $186,051,742 +$7,213,515 $5.83 54
2023 Q3 28,588,231 $73,196,468 +$2,177,876 $2.56 32
2023 Q2 27,951,619 $69,879,871 +$45,817,232 $2.5 28
2023 Q1 9,667,555 $20,309,551 +$609,616 $2.1 28
2022 Q4 9,519,305 $14,788,379 -$121,391 $1.55 28
2022 Q3 9,508,092 $29,003,732 -$530,741 $3.05 24
2022 Q2 9,682,082 $30,449,817 +$1,528,632 $3.14 23
2022 Q1 9,407,022 $26,340,000 -$1,500,189 $2.8 24
2021 Q4 9,861,945 $44,380,000 -$2,457,435 $4.5 28
2021 Q3 9,504,939 $78,230,000 +$78,229,998 $8.34 25